What does “Patient-Centricity” mean to clinical trial enrollment? Competitive ResearchSeptember 7, 2022 Read more
The Future of Clinical Trials is Decentralized’: Scott Stout, CEO of MedVector The Silicon Review IndustryJanuary 18, 2022 Read more
What does it take to change an Industry? Featuring Craig Lipset, Scott Stout and Ted Barduson at MedVector IndustrySeptember 28, 2021 Read more
Craig Lipset, Decentralized Clinical Trial Pioneer and Industry Innovator, Named as MedVector Board Member and Executive Advisor AnnouncementsJune 17, 2021 Read more
MedVector Unveils Prime-Control Technology to Expand Subject Enrollment in Clinical Trials AnnouncementsJune 8, 2021 Read more
How Virtual Clinical Trials Might Help Pharma’s Dangerous Diversity Problem IndustryJune 8, 2021 Read more
MedVector Launches its Prime-Control Technology to Expand Subject Enrollment Beyond Clinical Trial Sites AnnouncementsJune 8, 2021 Read more
MedVector Names John Neal, Chairman of PCRS Network, as Strategic Advisor, Pharma Relations and Clinical Protocol AnnouncementsApril 14, 2021 Read more
